Abstract:Yuan Liu, 1, 2,* Jing-Jing Zhao, 1, 2,* Zi-Qi Zhou, 1,2 Qiu-Zhong Pan, 1,2 Qian Zhu, 1,2 Yan Tang, 1,2 Jian-Chuan Xia, 1,2 De-Sheng Weng 1,2 1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China; 2 Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China *These authors contributed equally to this work Introduction: IL-37 is a cytokine of IL-1 family that plays an important role in innate immunity and inflammation, and has been studied as a tumor suppressor in many cancers. However, it remains unclear whether IL-37 plays a regulatory role in tumor-infiltrating dendritic cells (DCs) in hepatocellular carcinoma (HCC). Materials and methods: We evaluated the relationship between IL-37 expression and tumor infiltration by DCs in 155 HCC samples through immunohistochemical analysis and Kaplan–Meier survival analysis. The effects of IL-37 on the anti-tumor activity of DCs were investigated by ELISA, flow cytometry, real-time quantitative PCR, cytotoxicity assays and tumorigenicity assays. Results: The expression level of IL-37 in HCC samples was positively correlated with the degree of CD1a + DCs infiltration. The survival rates of patients with both a high expression of IL-37 and a high infiltration by CD1a + DCs were significantly higher than those of patients with a low expression of IL-37 and a low infiltration by CD1a + DCs. In vitro chemotaxis analysis indicated that HCC cells overexpressing IL-37 recruited more DCs by secreting higher levels of specific chemokines (eg, CCL3 and CCL20). In addition, IL-37 indirectly up-regulated the expression of major histocompatibility class II molecules, CD86 and CD40 on DCs by acting on tumor cells; IL-37 also indirectly enhanced the anti-tumor effect of T lymphocytes by stimulating DCs to secrete cytokines such as IL-2, IL-12, IL-12p70, interferon-α (IFN-α) and IFN-γ. Finally, overexpression IL-37 in HCC cells significantly delayed tumor growth and increased recruitment of CD11c + DCs to tumor tissues was also revealed in vivo mouse model. Conclusion: DCs play an important role in IL-37 mediated anti-tumor immune responses in HCC, which may contribute to the development of novel cancer immunotherapeutic strategies. Keywords: IL-37, dendritic cells, antitumor immunity, hepatocellular carcinoma

IL-37 suppresses migration and invasion of gallbladder cancer cells through inhibition of HIF-1α induced epithelial-mesenchymal transition.

IL-37 suppresses migration and invasion of gallbladder cancer cells through inhibition of HIF-1 alpha induced epithelial-mesenchymal transition

IL-37b Suppresses Epithelial Mesenchymal Transition in Hepatocellular Carcinoma by Inhibiting IL-6/STAT3 Signaling

Infiltrating Regulatory T Cells Promote Invasiveness of Liver Cancer Cells Via Inducing Epithelial-Mesenchymal Transition

IL-37d enhances COP1-mediated C/EBPβ degradation to suppress spontaneous neutrophil migration and tumor progression

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer

The role of IL-36 and 37 in hepatocellular carcinoma

Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression.

Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process

IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment

Interleukin 35 Activates Intratumor Neovascularization Via Enhanced Secretion of FGF2 in Hepatocellular Carcinoma Through The Recruitment of Neutrophils, and Blocking it Could Facilitate The Efficacy of The PD-1 Antibody

IL-37 mediates the antitumor activity in renal cell carcinoma

Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes

Therapeutic Potential of IL‐37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47‐Mediated Macrophage Phagocytosis

TW37 Enhances the Pro-Apoptosis and Anti-Migration Ability of Gefitinib in Non-Small Cell Lung Cancer.

Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction

Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform

IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation

Effect of insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) on migration and invasion of gallbladder cancer

Interleukin-35 expression promotes hepatocellular carcinogenesis by inducing γδ T-cell exhaustion